drugset / Trial / NCT00165698
Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine the effect and safety of menatetrenone on treatment of postmenopausal osteoporosis comparing with alfacalcidol.
Timeline
- Start
- 2005-05
- Primary completion
- 2007-01
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Alfacalcidol | Other / unclassified | 0.25 ug | Oral |
| Comparator | Menatetrenone | Unknown | 15 mg | Oral |